Libor Vı́tek
Impact in
-
- Neonatal Health and Biochemistry
- Molecular Biology top 1%
- Heme Oxygenase-1 and Carbon Monoxide
Papers in
-
- Heme Oxygenase-1 and Carbon Monoxide 105
-
- Neonatal Health and Biochemistry 98
- Co-authors
- Harvey A. Schwertner (5 shared papers)Ladislav Novotný (9 shared papers)Claudio Tiribelli (23 shared papers)Lucie Muchová (50 shared papers)Jaroslav Zelenka (24 shared papers)J. Donald Ostrow (3 shared papers)Martin Leníček (47 shared papers)Martin C. Carey (3 shared papers)
- Journals
- Scientific Reports (13 papers)Pediatric Research (8 papers)PLoS ONE (7 papers)International Journal of Molecular Sciences (7 papers)Physiological Research (7 papers)
- Partner nations
- CzechiaUnited StatesItaly
In The Last Decade
Libor Vı́tek
244 papers receiving 7.7k citations
Libor Vı́tek's Hit Papers
Peers
Comparison fields: 5 of 148
- Pediatrics, Perinatology and Child Health 2.6k
- Molecular Biology 4.2k
- Cell Biology 648
- Hepatology 258
- Biochemistry 223
Countries citing papers authored by Libor Vı́tek
This map shows the geographic impact of Libor Vı́tek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Libor Vı́tek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Libor Vı́tek more than expected).
Fields of papers citing papers by Libor Vı́tek
This network shows the impact of papers produced by Libor Vı́tek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Libor Vı́tek. The network helps show where Libor Vı́tek may publish in the future.
Co-authors
The 25 scholars most cited alongside Libor Vı́tek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 251 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 349 | |
| 2 | 2003 | 293 | |
| 3 | 2015 | 268 | |
| 4 | 2012 | 253 | |
| 5 | 2009 | 209 | |
| 6 | 2008 | 183 | |
| 7 | 2006 | 176 | |
| 8 | 2016 | 160 | |
| 9 | 2014 | 147 | |
| 10 | 2013 | 136 | |
| 11 | 2015 | 134 | |
| 12 | 2010 | 130 | |
| 13 | 2016 | 123 | |
| 14 | 2010 | 119 | |
| 15 | 2010 | 109 | |
| 16 | 2020 | 103 | |
| 17 | 2013 | 101 | |
| 18 | 2011 | 99 | |
| 19 | 2007 | 94 | |
| 20 | 2006 | 92 |
About Libor Vı́tek
Libor Vı́tek is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health, Surgery, Oncology and Pulmonary and Respiratory Medicine, having authored 251 papers that have together received 8.0k indexed citations. Recurring topics across this work include Heme Oxygenase-1 and Carbon Monoxide (105 papers), Neonatal Health and Biochemistry (98 papers), Drug Transport and Resistance Mechanisms (27 papers), Liver Disease Diagnosis and Treatment (22 papers), Hemoglobin structure and function (18 papers), Methemoglobinemia and Tumor Lysis Syndrome (16 papers), Alcohol Consumption and Health Effects (12 papers) and Cancer, Lipids, and Metabolism (10 papers). The work is most often cited by research in Pediatrics, Perinatology and Child Health (2.6k citations), Molecular Biology (4.2k citations), Cell Biology (648 citations), Hepatology (258 citations) and Biochemistry (223 citations). Libor Vı́tek has collaborated with scholars based in Czechia, United States and Italy. Frequent co-authors include Harvey A. Schwertner, Ladislav Novotný, Claudio Tiribelli, Lucie Muchová, Jaroslav Zelenka, J. Donald Ostrow, Martin Leníček, Martin C. Carey, Martin Haluzı́k and Petr Klán. Their work appears in journals such as Scientific Reports, Pediatric Research, PLoS ONE, International Journal of Molecular Sciences and Physiological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.